AstraZeneca : AZN

All AstraZeneca Articles

221 Articles

Rich Duprey | Jul 3, 2025 at 11:58 AM EDT

Quantum Computing Stocks: Billion-Dollar Groundbreaking Opportunity or Money Sinkhole?

Should You Invest in Quantum Computing Stocks? Quantum computing promises to revolutionize industries by solving complex problems beyond the reach…

Rich Duprey | May 13, 2025 at 12:21 PM EDT

Big Earnings Beats: 6 Stocks That Spiked After Reporting Results

We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.…

Gerelyn Terzo | Apr 3, 2025 at 10:24 AM EDT

Live Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff Ashes

The markets have succumbed to the tariff-fueled selling pressure, and there is nowhere to hide. President Trump’s tariff plan is…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Lee Jackson | Dec 30, 2024 at 11:14 AM EST

US Large Cap Dividend Stocks Should Roll in 2025: Our 4 Favorite Picks

These four large-cap dividend stocks offer value, upside potential, and strong dividend coverage. They are top picks for the coming…

Chris MacDonald | Dec 3, 2024 at 12:35 PM EST

3 Best Growth Stocks To Buy Now

Finding the “best” growth stocks to buy really is a subjective task, isn’t it? What’s considered to be the best…

Lee Jackson | Oct 13, 2024 at 2:40 PM EDT

5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever

These five blue chip dividend stocks would be ideal for investors who had to hold them forever, as they provide…

Chris MacDonald | Oct 7, 2024 at 12:44 PM EDT

Like Him Or Hate Him, George Soros Is Betting Big On These 3 Stocks You Should Be Watching

George Soros is among the most renowned and controversial hedge fund managers on the planet. Well known for his political…

Rich Duprey | Sep 20, 2024 at 8:20 AM EDT

George Soros $4 Billion Hedge Fund Can’t Stop Buying These 3 Stocks

Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making…

Trey Thoelcke | Sep 19, 2024 at 9:15 AM EDT

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are…

Lee Jackson | Jul 10, 2024 at 8:44 AM EDT

Deutsche Bank Has 4 Sizzling ‘Fresh Money’ Dividend Stock Picks for Q3

24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter. Stocks that…

Lee Jackson | Jul 2, 2024 at 10:10 AM EDT

Buy These 7 Dividend Stocks and Hold Forever

24/7 Insights Quality dividend stocks outperform non-dividend stocks for shareholders. Dividend stocks can deliver dependable passive income streams. Access 2…

Trey Thoelcke | Mar 15, 2024 at 9:15 AM EDT

This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery

With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high…

Trey Thoelcke | Jan 26, 2024 at 9:49 AM EST

How Safe Is AbbVie Stock’s 3.7% Dividend?

Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics,…

Lee Jackson | Jan 3, 2024 at 8:45 AM EST

4 Red-Hot Stocks Top Wednesday’s Biggest Wall Street Upgrades and Downgrades

Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.

1 2 3 4 … 15

AstraZeneca : AZN

All AstraZeneca Articles

Quantum Computing Stocks: Billion-Dollar Groundbreaking Opportunity or Money Sinkhole?

Big Earnings Beats: 6 Stocks That Spiked After Reporting Results

Live Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff Ashes

AbbVie Just Paid Investors: Here’s How Much They Received

US Large Cap Dividend Stocks Should Roll in 2025: Our 4 Favorite Picks

3 Best Growth Stocks To Buy Now

5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever

Like Him Or Hate Him, George Soros Is Betting Big On These 3 Stocks You Should Be Watching

George Soros $4 Billion Hedge Fund Can’t Stop Buying These 3 Stocks

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Deutsche Bank Has 4 Sizzling ‘Fresh Money’ Dividend Stock Picks for Q3

Buy These 7 Dividend Stocks and Hold Forever

This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery

How Safe Is AbbVie Stock’s 3.7% Dividend?

4 Red-Hot Stocks Top Wednesday’s Biggest Wall Street Upgrades and Downgrades

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

AstraZeneca : AZN

All AstraZeneca Articles

Quantum Computing Stocks: Billion-Dollar Groundbreaking Opportunity or Money Sinkhole?

Big Earnings Beats: 6 Stocks That Spiked After Reporting Results

Live Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff Ashes

AbbVie Just Paid Investors: Here’s How Much They Received

US Large Cap Dividend Stocks Should Roll in 2025: Our 4 Favorite Picks

3 Best Growth Stocks To Buy Now

5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever

Like Him Or Hate Him, George Soros Is Betting Big On These 3 Stocks You Should Be Watching

George Soros $4 Billion Hedge Fund Can’t Stop Buying These 3 Stocks

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Deutsche Bank Has 4 Sizzling ‘Fresh Money’ Dividend Stock Picks for Q3

Buy These 7 Dividend Stocks and Hold Forever

This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery

How Safe Is AbbVie Stock’s 3.7% Dividend?

4 Red-Hot Stocks Top Wednesday’s Biggest Wall Street Upgrades and Downgrades

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.